Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RecruitingNCT05981183Phase: NAStarted 2023-08-09
Summary
The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney di
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
NYU Langone HealthNew York, New York, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05981183